Immunosuppression To Fit the Patient
RESEARCHERS have identified a gene signature that may enable clinicians to distinguish which renal transplant recipients could be eligible for a progressive decrease in their immunosuppressive medications and who needs to stay on their current dose.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.